Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Hui Ping Wan"'
Publikováno v:
Molecular Medicine Reports
Triple-negative breast cancer (TNBC) is associated with an aggressive clinical history, high risk of recurrence and metastasis, and shorter patient survival due to lack of targeted therapy. In the present study, UNC0638, a chemical G9a inhibitor, was
Publikováno v:
Asia Pacific journal of clinical nutrition. 25(4)
The present study was conducted to evaluate the effect of cod skin peptide (CSPE) on chemotherapy-induced toxicity in gastric cancer patients.A cohort of 60 gastric cancer patients for chemotherapy was randomly divided into two groups (n=30 per group
Autor:
Nong Xu, Jian Ping Xiong, Ding Zhi Huang, Yang Zhang, Zhuang Yu, Yi Ba, Zhong He Yu, Ting Deng, Zeng Qing Guo, Rong Sheng Zheng, Mei Ling Wang, Chun Hong Hu, Yang Yao, Zhao Yan, Zhi Xiang Zhuang, Hui Ping Wan, Ji Chang Meng
Publikováno v:
Journal of chemotherapy (Florence, Italy). 25(1)
To report the results of a safety analysis from a phase II trial comparing administration of weekly paclitaxel plus S-1 (TS) versus paclitaxel plus 5-fluorouracil (5-FU)/calcium folinate (LV) (TLF) as first-line therapy for advanced gastric cancer.Pa
Autor:
Ding-zhi, Huang, Jian-ping, Xiong, Nong, Xu, Zhao, Yan, Zhi-xiang, Zhuang, Zhuang, Yu, Hui-ping, Wan, Yang, Zhang, Ting, Deng, Rong-sheng, Zheng, Zeng-qing, Guo, Chun-hong, Hu, Mei-Ling, Wang, Zhong-He, Yu, Yang, Yao, Ji-chang, Meng, Yi, Ba
Publikováno v:
Zhonghua zhong liu za zhi [Chinese journal of oncology]. 34(11)
To evaluate the efficacy and safety of weekly paclitaxel combined with S-1 or fluorouracil in the first line treatment of advanced gastric carcinoma.Two hundred and forty patients with untreated advanced gastric carcinoma were randomized into two arm